Acute effects of inhaled iloprost in portopulmonary hypertension

M. T. Melgosa, J. C. Garcia-Pagan, J. L. Valera, J. Turnes, G. Ricci, J. Roca, R. Rodriguez-Roisin, J. A. Barberà (Barcelona, Spain)

Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Session: Pulmonary arterial hypertension: from bench back to bedside
Session type: Poster Discussion
Number: 3157
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. T. Melgosa, J. C. Garcia-Pagan, J. L. Valera, J. Turnes, G. Ricci, J. Roca, R. Rodriguez-Roisin, J. A. Barberà (Barcelona, Spain). Acute effects of inhaled iloprost in portopulmonary hypertension. Eur Respir J 2006; 28: Suppl. 50, 3157

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled iloprost for patients with portopulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 462s
Year: 2003

Experience with inhaled iloprost and bosentan in portopulmonary hypertension
Source: Eur Respir J 2007; 30: 1096-1102
Year: 2007



Acute effects of Sildenafil and Iloprost in pulmonary hypertension of various aetiology
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002

Inhaled iloprost reverses chronic experimental pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005

Sildenafil treatment for portopulmonary hypertension
Source: Eur Respir J 2006; 28: 563-567
Year: 2006



Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 8-13
Year: 2001



Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 339-343
Year: 2002



Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006 Oct 01;28(4):691-694
Year: 2006



Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 1334-1335
Year: 2001


Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 18: 247
Year: 2001


Iloprost treatment in portopulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol
Source: Eur Respir J 2001; 18: Suppl. 33, 323s
Year: 2001

Pharmacokinetic differences between inhaled treprostinil and inhaled iloprost in severe pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004

Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002

Inhaled iloprost in HIV-related pulmonary arterial hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004

Experience with inhaled iloprost in paediatric pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011


Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002

Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002

Inhaled iloprost for the treatment of pulmonary hypertension
Source: Eur Respir Rev 2009; 18: 29-34
Year: 2009


Inhaled iloprost plus oral sildenafil in patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001